Page results
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
CAMLIS is the Royal London Hospital for Integrated Medicine (RLHIM) Complementary and Alternative Medicine Information and Library Service and is situated on the ground floor of the hospital.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease.
-
Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
UCLH is continuing to scale up the number of services that offer Advice & Guidance, as well as identifying various improvements within the existing Advice & Guidance service. Over the last few months, UCLH has introduced 5 new specialties to the service, with additional specialties due to go live shortly.
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
File results
-
FOI/2023/0394 - Business continuity plans for telecommunications system/ bleep/ switchboard
-
FOI/2023/0396 - Compensation paid for maternity claims 2022/23
-
FOI/2023/0399 - Patient deaths while waiting to receive planned care/ patients waiting more than 18 weeks - 2022
-
FOI/2023/0401 - Patient treatments for brain tumour from 2018-2022
-
FOI/2023/0402 - Migraine treatment/ medication
-
FOI/2023/0403 - Patients detained under the Mental Health Act - 2018-2023
-
FOI/2023/0410 - Clinical systems at the Trust
-
FOI/2023/0413 - Care hotels for patients used/ booked by Trust - 2022/23
-
FOI/2023/0414 - Operation cancelled for non-clinical reasons - 2018-2022
-
FOI/2023/0415 - Contact details for senior staff at Estates and Facilities